Skip to content

Solana Strep Complete Assay

by Quidel Corporation

510(k) K162274

Solana Strep Complete Assay is a medical device (FDA Class II; FDA product code PGX, Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System) made by Quidel Corporation, cleared under FDA 510(k) K162274 on 25 Oct 2016, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK162274 Date25 Oct 2016ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Aug 2016
FDA decision
25 Oct 2016 (Substantially Equivalent)
FDA review time
74 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K162274 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
PGX
Device class
Class II
Regulation
21 CFR Part 866.2680
Advisory committee
Microbiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System).

Other devices from Quidel Corp.

See all devices from Quidel Corp. →